Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;33(38):e2102580.
doi: 10.1002/adma.202102580. Epub 2021 Aug 4.

Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy

Affiliations
Review

Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy

Zhaoting Li et al. Adv Mater. 2021 Sep.

Abstract

Bacteria are one of the main groups of organisms, which dynamically and closely participate in human health and disease development. With the integration of chemical biotechnology, bacteria have been utilized as an emerging delivery system for various biomedical applications. Given the unique features of bacteria such as their intrinsic biocompatibility and motility, bacteria-based delivery systems have drawn wide interest in the diagnosis and treatment of various diseases, including cancer, infectious diseases, kidney failure, and hyperammonemia. Notably, at the interface of chemical biotechnology and bacteria, many research opportunities have been initiated, opening a promising frontier in biomedical application. Herein, the current synergy of chemical biotechnology and bacteria, the design principles for bacteria-based delivery systems, the microbial modulation, and the clinical translation are reviewed, with a special focus on the emerging advances in diagnosis and therapy.

Keywords: bacteria; bioengineering; chemical engineering; diagnosis; therapy.

PubMed Disclaimer

References

    1. E. A. Franzosa, A. Sirota-Madi, J. Avila-Pacheco, N. Fornelos, H. J. Haiser, S. Reinker, T. Vatanen, A. B. Hall, H. Mallick, L. J. McIver, J. S. Sauk, R. G. Wilson, B. W. Stevens, J. M. Scott, K. Pierce, A. A. Deik, K. Bullock, F. Imhann, J. A. Porter, A. Zhernakova, J. Fu, R. K. Weersma, C. Wijmenga, C. B. Clish, H. Vlamakis, C. Huttenhower, R. J. Xavier, Nat. Microbiol. 2019, 4, 293.
    1. a) J. R. Singer, E. G. Blosser, C. L. Zindl, D. J. Silberger, S. Conlan, V. A. Laufer, D. DiToro, C. Deming, R. Kumar, C. D. Morrow, J. A. Segre, M. J. Gray, D. A. Randolph, C. T. Weaver, Nat. Med. 2019, 25, 1772;
    1. b) J. Gupta, V. Kaul, S. Easaw, L. Alex, M. Warshawsky, Chest 2017, 152, A349;
    1. c) S. Balayan, N. Chauhan, R. Chandra, N. K. Kuchhal, U. Jain, Biosens. Bioelectron. 2020, 169, 112552;
    1. d) D. Nader, G. F. Curley, S. W. Kerrigan, Drug Discovery Today 2020, 25, 2317.

LinkOut - more resources